GREGORY LYNCH: Open Payments
NPI 1790008175 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,160 in 87 payments from 16 companies in 2025. Trend: 2023 $2,177 · 2024 $1,539 · 2025 $3,160
Food & beverage: $2,032Consulting: $1,080Education: $48
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $1,380 |
| GENZYME CORPORATION | 12 | $342 |
| Novartis Pharmaceuticals Corporation | 11 | $280 |
| LEO Pharma Inc. | 14 | $276 |
| ABBVIE INC. | 12 | $198 |
| Janssen Biotech, Inc. | 6 | $169 |
| Amgen Inc. | 13 | $150 |
| Arcutis Biotherapeutics, Inc. | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $61 |
| UCB, Inc. | 3 | $54 |
Products named: Winlevi, DUPIXENT, ADBRY, COSENTYX, TREMFYA, Otezla, SKYRIZI, Rhapsido.
Industry payments across CA — which companies pay providers there.
